Bharat Immunologicals & Biologicals Corporation Ltd.

31.94 +0.06 ▲0.2%

05 March 2024, 10:49:00 AM
Volume: 22,942

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.bibcol.com
Market Cap 137.66 Cr.
Enterprise Value(EV) 203.11 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -3.85 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03
Industry PE 41.59 Trailing Twelve Months Ending 2023-03
Book Value / Share -7.54 Trailing Twelve Months Ending 2023-03
Price to Book Value -4.23 Calculated using Price: 31.88
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 4.32 Cr. 43,180,000 Shares
FaceValue 10
About Bharat Immunologicals & Biologicals Corporation Ltd.
The Company's principal activity is to manufacture and supply of oral polio vaccine. It supplies oral polio vaccine to Government of India. Its plant is located in Bulandshahr, Uttar Pradesh.

Bharat Immunologicals & Biologicals Corporation Ltd. Delivery

Delivered Qty
Traded Qty

Bharat Immunologicals & Biologicals Corporation Ltd. Performance

1 Day
+0.19%
1 Week
-3.30%
1 Month
-12.95%
3 Month
+17.99%
6 Month
+29.57%
1 Year
+39.48%
2 Year
-13.09%
5 Year
+269.25%
10 Year
+255.28%

Bharat Immunologicals & Biologicals Corporation Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 3.81 -16.25 16.94 -10.76 -17 -39.93 -158.64 0 0
Return on Capital Employed (%) 9.07 -8.52 31.11 -17.52 -10.7 -21.87 -73.05 -8.08 -25.63
Return on Assets (%) 1.81 -8.5 10.8 -8.51 -7.22 -8.97 -18.41 -6.35 -9.41

Bharat Immunologicals & Biologicals Corporation Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 41 35 42 38 31 20 34 105 88 79
Non Curr. Liab. 4 1 -1 -5 -4 -8 -14 -15 -20 -19
Curr. Liab. 35 30 14 13 88 101 64 101 94 99
Minority Int.
Equity & Liab. 80 66 55 45 115 113 84 192 162 158
Non Curr. Assets 7 6 8 7 16 20 50 126 126 126
Curr. Assets 74 60 47 38 99 93 34 65 36 33
Misc. Exp. not W/O
Total Assets 80 66 55 45 115 113 84 192 162 158

Bharat Immunologicals & Biologicals Corporation Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 146 128 124 35 84 67 85 78 45 26
Other Income 1 1 1 1 4 1 2 1 1 1
Total Income 147 129 125 36 88 68 87 79 46 27
Total Expenditure -143 -132 -111 -43 -93 -77 -106 -83 -61 -43
PBIDT 4 -3 14 -7 -5 -9 -19 -4 -15 -16
Interest -1 -6 -4 -1 -2 -5 -5 -6 -7 -7
Depreciation -1 -1 -1 0 0 0 0 0 0 0
Taxation -1 3 -3 4 2 4 6 1 6 6
Exceptional Items
PAT 2 -6 7 -4 -6 -10 -18 -9 -17 -17
Adjusted EPS 0 -1 2 -1 -1 -2 -4 -2 -4 -4

Bharat Immunologicals & Biologicals Corporation Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -12 8 -9 -17 3 -32 34 12 -42 11
Cash Fr. Inv. 0 0 1 1 1 1 1 1 1 0
Cash Fr. Finan. -6 -1 -2 -3 -3 31 -34 -12 45 -15
Net Change -18 7 -10 -20 1 -1 1 0 3 -3
Cash & Cash Eqvt 23 30 20 0 1 0 1 1 5 1

Bharat Immunologicals & Biologicals Corporation Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 59.25 59.25 59.25 59.25 59.25 59.25 59.25 59.25 59.25
Public 40.75 40.75 40.75 40.75 40.75 40.75 40.75 40.75 40.75
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Bharat Immunologicals & Biologicals Corporation Ltd. Announcements

Thu, 29 Feb 2024
Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBI'S LODR.
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 08th March 2024 for General Purpose.
Wed, 13 Dec 2023
Compliance Of Regulation 34 Of LODR 2015 And Submission Annual Report For 34Th Annual General Meeting Scheduled On 29.12.2023.
Submission of Draft Annual Report 2022-23 for AGM on 29.12.2023
Tue, 28 Nov 2023
Submission Of Notice Of 34Th Annual General Meeting On 29.12.2023 As Compliance Of The Provision Of LODR 2015.
Annual General Meeting of Shareholders for the year 2022-23 is scheduled to be held on 29.12.2023.Submitted for kind information and record please.

Bharat Immunologicals & Biologicals Corporation Ltd. Technical Scans

Mon, 04 Mar 2024
High Delivery Percentage High Delivery Percentage
Closing Below Previous Low Closing Below Previous Low
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 3 Months High Increase in 3 Months

Bharat Immunologicals & Biologicals Corporation Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 372,436.77 1,546.05 -0.4%
Cipla Ltd. 118,783.64 1,465.75 -0.4%
Dr. Reddy's Laboratories Ltd. 105,691.98 6,269.85 -1.0%
Zydus Lifesciences Ltd. 95,764.63 944.00 -0.2%
Divi's Laboratories Ltd. 92,421.56 3,461.00 -0.6%
Torrent Pharmaceuticals Ltd. 91,038.44 2,684.50 -0.2%
Apollo Hospitals Enterprise Ltd. 86,787.70 6,027.30 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.82 1,546.05 -0.4%
Cipla Ltd. Consolidated 2023-12 32.03 1,465.75 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.22 6,269.85 -1.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.20 944.00 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 66.83 3,461.00 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.94 2,684.50 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 109.95 6,027.30 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.97 1,546.05 -0.4%
Cipla Ltd. Consolidated 2023-12 4.59 1,465.75 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.93 6,269.85 -1.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.93 944.00 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 7.09 3,461.00 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.73 2,684.50 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 12.85 6,027.30 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,546.05 -0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,465.75 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,269.85 -1.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 944.00 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,461.00 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,684.50 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,027.30 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,546.05 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,465.75 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,269.85 -1.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 944.00 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,461.00 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,684.50 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,027.30 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,546.05 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,465.75 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,269.85 -1.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 944.00 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,461.00 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,684.50 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,027.30 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,546.05 -0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,465.75 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,269.85 -1.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 944.00 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,461.00 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,684.50 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,027.30 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,546.05 -0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,465.75 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,269.85 -1.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 944.00 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,461.00 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,684.50 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,027.30 -0.1%

Bharat Immunologicals & Biologicals Corporation Ltd. FAQ's

What is Bharat Immunological share price?

Can I buy Bharat Immunological shares now?

What is the Market Cap of Bharat Immunological?

What is the 52 Week High and Low of Bharat Immunological?

What is the trend of Bharat Immunological share price?